| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e4d3181f76ddc8b09af6fda4f72804d9 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135 |
| filingDate |
2011-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ee2302e37151702af9c0a09d1b87b01a |
| publicationDate |
2012-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2012060860-A1 |
| titleOfInvention |
Treatment of ocular and cerebral ischemia |
| abstract |
Ocular and cerebral blood flow are enhanced by the administration of (-) erythro isomer of α-methyl epinephrine, a C 1 to C 8 aliphatic ester of α-methyl epinephrine, α-methyl norepinephrine, a C 1 to C 8 aliphatic ester of α-methyl norepinephrine, or a pharmacologically acceptable acid addition salt thereof. |
| priorityDate |
2010-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |